ライノメトリーシステムの世界市場-2023年～2030年

概要

ライノメトリーとは、呼吸時の鼻圧と気流を測定するもので、鼻の気道抵抗を測定し、鼻の開通性を評価する標準的な技術として認められています。音響式ライノメトリーでは、反射音信号を用いて鼻腔の断面積と容積を測定します。

ライノメトリーは、手術のための患者選択を改善し、鼻閉の構造的原因と機能的原因を区別し、鼻弁閉鎖不全を診断し、矛盾する症状と検査所見を明確にし、医療法学的ツールとして便利で、鼻アレルゲンの治療ツールとして使われています。

市場力学：促進・抑制要因

アレルギー性鼻炎の有病率の上昇

アレルギー性鼻炎の有病率の上昇は、予測期間中のライノメトリーシステム市場を牽引する重要な主要因の1つです。例えば、National Library of Medicine 2023に掲載された論文によると、アレルギー性鼻炎の有病率は、2017年から2022年の間に1.83%から9.23%となりました。COVID-19パンデミックの前後では、21.38から70.22%と大幅に減少しています。6歳から18歳の場合、女性よりも男性の方が有病率が高くなりました。こうした要因が、予測期間中の市場成長を促進するのに役立ちます。

さらに、世界のライノメトリーシステム市場は、ライノメトリーの技術進歩、鼻疾患の有病率の上昇、非侵襲的診断技術の普及など、さまざまな要因によっても牽引されており、それが予測期間中の市場成長を後押しします。

市場力学：抑制要因

ライノメトリーシステムの関連コストの高さや、ライノメトリーシステムの初期投資と整備コストは相当な額になる可能性があり、特に発展途上地域の医療施設にとって課題となります。こうしたシステム関連コストの高さが、その採用を制限し、市場の成長を妨げる可能性があります。

また、熟練した専門家が不足しているため、ライノメトリーシステムを効果的に使用するには、これらの機器から得られたデータを正確に解釈できる訓練を受けた医療専門家が必要です。一部の地域では熟練した人材が不足しており、市場成長の抑制要因となる可能性があります。ライノメトリーシステムの使用法と解釈について医療専門家を訓練・教育する努力が必要です。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • アレルギー性鼻炎の有病率の上昇
    • 技術進歩
  • 抑制要因
    • 装置の関連コストの高さ
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• ロシア・ウクライナ戦争の影響分析
• DMIの見解

第6章 COVID-19分析

第7章 製品タイプ別

• 音響式ライノメトリー
• 光学式ライノメトリー
• インピーダンス式ライノメトリー

第8章 用途別

• アレルギー診断
• 鼻の手術
• 呼吸器疾患診断
• その他

第9章 エンドユーザー別

• 病院
• 耳鼻咽喉科クリニック
• 外来手術センター
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第12章 企業プロファイル

• Happersberger otopront GmbH
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な動向
• ECLERIS
• GM Instruments
• Homoth Medizinelektronik GmbH & Co
• Recorders and Medicare
• ATMOS MedizinTechnik GmbH
• Sensonics International
• Piston Medical
• BioRESEARCH Associates, Inc
• HealthManagement

第13章 付録

Overview

Rhinomanometry, which measures nasal pressure and airflow during breathing, is accepted as the standard technique for measuring nasal airway resistance and assessing the patency of the nose. Acoustic rhinometry uses a reflected sound signal to measure the cross-sectional area and volume of the nasal passage.

Rhinomanometry is useful to improve patient selection for surgery, distinguish between structural and functional causes of nasal obstruction, diagnose nasal valve collapse, clarify conflicting symptoms and exam findings, use as a medicolegal tool and in nasal allergen challenges.

Market Dynamics: Drivers and Restraints

Rise in the prevalence of allergic rhinitis

The rise in the prevalence of allergic rhinitis is one of the significant key factors that drive the rhinometry systems market during the forecast period. For instance, according to the article published in the National Library of Medicine 2023, the prevalence of allergic rhinitis cases ranged from 1.83 to 9.23% between 2017 and 2022. There was a significant drop of 21.38 to 70.22% between the pre- and post-COVID-19 pandemic. Males were more prevalent in the 6 to 18-year-olds than females. Thus, the above factors help to drive market growth during the forecast period.

Furthermore, the global rhinometry systems market is also driven by various factors like technological advancements in rhinometry, a rise in the prevalence of nasal disorders, a rise in non-invasive diagnostic techniques and others that will drive the market growth during the forecast period.

Market Dynamics: Restraint

High costs associated with rhinometry systems, the initial investment and maintenance costs of rhinometry systems can be substantial, posing a challenge for healthcare facilities, particularly in developing regions. The high costs associated with these systems may limit their adoption, hindering market growth.

Also, lack of skilled professionals the effective use of rhinometry systems requires trained healthcare professionals who can accurately interpret the data obtained from these devices. The shortage of skilled personnel in certain regions may pose a restraint to market growth. Efforts should be made to train and educate healthcare professionals on the usage and interpretation of rhinometry systems.

Segment Analysis

The global rhinometry systems is segmented based on product type, application, end-user and region.

The acoustic rhinometry from the product type segment accounted for approximately 41.2% of the market share

The acoustic rhinometry from the product type segment accounted for 41.2% and it is expected to be dominated during the forecast period. Acoustic rhinometry is a new technique which evaluates nasal obstruction by analysing reflections of a sound pulse introduced via the nostrils. The technique is rapid, reproducible, non-invasive and requires minimal cooperation from the subject. Unlike rhinomanometry, it does not require airflow. A graph of the nasal cross-sectional area as a function of distance from the nostril is produced, from which several area and volume estimates of the nasal cavity can be derived.

The role of acoustic rhinometry in diagnosis is quantifying nasal obstruction. This procedure is particularly important with secondary rhinoplasty patients whose complaints include substantial functional problems in addition to aesthetic concerns.

Geographical Analysis

North America accounted for approximately 38.4% of the market share in 2022

North America is estimated to hold about 38.4% of the total market share throughout the forecast period, owing to be attributed to well-established healthcare infrastructure, rising prevalence of septal deviation, and technological advancements in rhinometry systems in the region. In terms of revenue.

For instance, in March 2020, GM Instruments stated that an exclusive distribution partnership with BioResearch Associates Inc. This partnership supports the North American market expansion into the dental/dental sleep market with a reputable partner experienced in innovative ENT products.

Alongside our distribution partner, we are implementing a collaborative, interdisciplinary approach to patient care and outcomes with a network of dentists and ENTs. There is a need for healthcare policy financial considerations and if 20% of the patients undergoing unnecessary septal surgical intervention were identified pre-operatively then potentially 12 million pounds could be saved with an additional significant reduction in the number of NHS hospital bed days wasted.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the healthcare industry, including the rhinometry systems market. The pandemic has highlighted the importance of non-invasive diagnostic techniques, remote monitoring, and telemedicine. Rhinometry systems, with their non-invasive nature and potential for remote patient care, have gained prominence during the pandemic.

Competitive Landscape

The major global players in the rhinometry systems market include Happersberger otopront GmbH , ECLERIS, GM Instruments, Homoth Medizinelektronik GmbH & Co, Recorders and Medicare, ATMOS MedizinTechnik GmbH , Sensonics International , Piston Medical, BioRESEARCH Associates, Inc, HealthManagement and among others.

Key Developments

• In June 2022, Vivos Therapeutics signed an exclusive distribution agreement with GM Instruments for the NR6 Rhinomanometer, an FDA-approved device used to measure nasal airway resistance, for treating dentofacial abnormalities and OSA in adults.

Why Purchase the Report?

• To visualize the global rhinometry systems market segmentation-based product type, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of rhinometry systems market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global rhinometry systems market report would provide approximately 69 tables, 70 figures, and 185 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Application
• 3.3. Snippet by End User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Driver
    • 4.1.1.1. Rise in the prevalence of allergic rhinitis
    • 4.1.1.2. Rise in the technology advancements
  • 4.1.2. Restraints
    • 4.1.2.1. High cost associated with the equipment
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Russia-Ukraine War Impact Analysis
• 5.6. DMI Opinion

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID
  • 6.1.2. Scenario During COVID
  • 6.1.3. Scenario Post COVID
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Product Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 7.1.2. Market Attractiveness Index, By Product Type
• 7.2. Acoustic Rhinometry *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Optical Rhinometry
• 7.4. Impedance Rhinometry

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Allergy Diagnosis*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Nasal Surgery
• 8.4. Respiratory Disease Diagnosis
• 8.5. Others

9. By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.1.2. Market Attractiveness Index, By End User
• 9.2. Hospitals *
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. ENT Clinics
• 9.4. Ambulatory Surgical Centers
• 9.5. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. UK
    • 10.3.6.3. France
    • 10.3.6.4. Italy
    • 10.3.6.5. Spain
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.5.1. Brazil
    • 10.4.5.2. Argentina
    • 10.4.5.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.5.1. China
    • 10.5.5.2. India
    • 10.5.5.3. Japan
    • 10.5.5.4. Australia
    • 10.5.5.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Happersberger otopront GmbH
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. ECLERIS
• 12.3. GM Instruments
• 12.4. Homoth Medizinelektronik GmbH & Co
• 12.5. Recorders and Medicare
• 12.6. ATMOS MedizinTechnik GmbH
• 12.7. Sensonics International
• 12.8. Piston Medical
• 12.9. BioRESEARCH Associates, Inc
• 12.10. HealthManagement

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us